Vanda Pharmaceuticals Inc.
$322.90M- Market cap
- $329.52M
- Debt
- +$78.23M
- Cash
- −$84.85M
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · current priceP/S 1.52x
$5.45Latest market snapshot
Implied fair value · at PAHC's multiple
$6.2113.9% above market
3.57 VNDA revenue / share×1.74x PAHC P/S=$6.21
Market $5.45Implied $6.21
PAHC · current priceP/S 1.74x
$38.27Latest market snapshot
Implied fair value · at VNDA's multiple
$57.0949.2% above market
37.44 PAHC revenue / share×1.52x VNDA P/S=$57.09
Market $38.27Implied $57.09